Literature DB >> 7705162

Snoring, apneic episodes, and nocturnal hypoxemia among children 6 months to 6 years old. An epidemiologic study of lower limit of prevalence.

T Gislason1, B Benediktsdóttir.   

Abstract

STUDY
OBJECTIVE: To identify a lower limit of the prevalence of sleep-related breathing disturbances among preschool children.
DESIGN: A cross-sectional epidemiologic study in two stages, first by questionnaires and second by whole-night investigation of children symptomatic of the sleep apnea syndrome.
SETTING: Gardabaer, a small town, 10 km south of Reykjavìk, Iceland. PARTICIPANTS: All children in Gardabaer, 6 months to 6 years old (n = 555). MEASUREMENTS: Symptom score estimated by questionnaire and respiratory events based on overnight oximetry, thermistors, and a static charge sensitive bed.
RESULTS: The response rate was 81.8%. Snoring was reported as often or very often among 14 (3.2%) and occasionally by 73 (16.7%). Apneic episodes were reported often or very often among seven (1.6%). Altogether 18 children were highly suspected of the sleep apnea syndrome because of habitual snoring or apneic episodes. The girls (n = 9) were older than the boys (mean age: 46 +/- 21 months vs 20 +/- 12 months, p < 0.001). Eventually 11 children came for a whole-night investigation and 8 of them showed more than three respiratory events per hour of sleep, associated with > or = 4% oxygen desaturation. The lower limit of the sleep apnea syndrome prevalence among these children was thus 2.9% (SE, 0.5%).
CONCLUSIONS: Among children, symptoms such as snoring and apneic episodes are reported relatively seldom, but a high proportion of the children with these symptoms have hypoxic respiratory events.

Entities:  

Mesh:

Year:  1995        PMID: 7705162     DOI: 10.1378/chest.107.4.963

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  76 in total

1.  Are sleep studies worth doing?

Authors:  V van Someren; M Burmester; G Alusi; R Lane
Journal:  Arch Dis Child       Date:  2000-07       Impact factor: 3.791

Review 2.  Epidemiology of allergic rhinitis.

Authors:  R Michael Sly
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

Review 3.  Who should have a sleep study for sleep related breathing disorders?

Authors:  L Whiteford; P Fleming; A J Henderson
Journal:  Arch Dis Child       Date:  2004-09       Impact factor: 3.791

4.  The relation between childhood obesity and adenotonsillar hypertrophy.

Authors:  Ghaniya Daar; Kamran Sarı; Zeliha Kapusuz Gencer; Hüseyin Ede; Reha Aydın; Levent Saydam
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-10       Impact factor: 2.503

Review 5.  Sleep . 8: paediatric obstructive sleep apnoea.

Authors:  G M Nixon; R T Brouillette
Journal:  Thorax       Date:  2005-06       Impact factor: 9.139

6.  Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease.

Authors:  Shikha S Sundaram; Ronald J Sokol; Kelley E Capocelli; Zhaoxing Pan; Jillian S Sullivan; Kristen Robbins; Ann C Halbower
Journal:  J Pediatr       Date:  2013-12-07       Impact factor: 4.406

7.  Blood pressure in sleep disordered breathing.

Authors:  J Kohyama; J S Ohinata; T Hasegawa
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

8.  Obstructive sleep apnea in sleepy pediatric psychiatry clinic patients: polysomnographic and clinical correlates.

Authors:  J F Pagel; Steve Snyder; Dawn Dawson
Journal:  Sleep Breath       Date:  2004-09       Impact factor: 2.816

9.  Oxidative stress in children with obstructive sleep apnea syndrome.

Authors:  Riva Tauman; Lena Lavie; Michal Greenfeld; Yakov Sivan
Journal:  J Clin Sleep Med       Date:  2014-06-15       Impact factor: 4.062

10.  No relationship between neurocognitive functioning and mild sleep disordered breathing in a community sample of children.

Authors:  Susan L Calhoun; Susan D Mayes; Alexandros N Vgontzas; Marina Tsaoussoglou; Laura J Shifflett; Edward O Bixler
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.